Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4370-4376

  Usui, Tomohiko ^a   Sugisaki, Kenji ^a   Iriyama, Aya ^a   Yokoo, Seiichi ^a   Yamagami, Satoru ^a   Nagai, Norihiro ^b   Ishida, Susumu ^b   Amano, Shiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NYLON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CCL2 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; SUTURE; SUTURING METHOD; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CORNEA STROMA; GENETICS; METABOLISM; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BLOTTING, WESTERN; CHEMOKINE CCL2; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; EPITHELIUM, CORNEAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 53449087211     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0964     Document Type: Article

References (30)

1. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation- related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22. (Pubitemid 28040457)
2. Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res. 2006;82:46-54. (Pubitemid 43063396)
3. Yoshida S, Yoshida A, Matsui H, Takada Y, Ishibashi T. Involvement of macrophage chemotactic protein-1 and interleukin-1 beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea. Lab Invest. 2003;83:927-938. (Pubitemid 36899060)
4. Gan L, Fagerholm, Palmblad J. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand. 2004;82:557-563. (Pubitemid 39386968)
5. Gard PR. The role of angiotensin II in cognition and behavior. Eur J Pharmacol. 2002;438:1-14.
6. Hernandez-Presa M, Bustos C, Ortego M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit mode of early accelerated atherosclerosis. Circulation. 1997;95:1532-1541. (Pubitemid 27142812)
7. Pastore L, Tessitore A, Martinotti S, et al. Angiotensin II stimulates intracellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation. 1999;100:1646-1652. (Pubitemid 29477275)
8. Grafe M, Auch-Schwelk W, Zakrzewicz A, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res. 1997;81:804-811. (Pubitemid 27467215)
9. Okamura A, Rakugi H, Ohnishi M, et al. Upregulation of reninangiotensin system during differentiation of monocytes to macrophages. J Hypertens. 1999;17:537-545. (Pubitemid 29308564)
10. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochem Biophys Acta. 1998;1401:187-194. (Pubitemid 28129101)
11. Candido R, Allen TJ, Lassila M, et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation. 2004;109:1536-1542. (Pubitemid 38420183)
12. Nagai N, Oike Y, Izumi-Nagai K, et al. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol. 2006;26:2252-2259. (Pubitemid 44465719)
13. Nagai N, Noda K, Urano T, et al. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type I receptor. Invest Ophthalmol Vis Sci. 2005;46:1078-1084. (Pubitemid 41321048)
14. Zhu SN, Dana MR. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci. 1999;40:1427-1434.
15. Moromizato Y, Stechschulte S, Miyamoto K, et al. CD18 and ICAM-1 dependent neovascularization and inflammation after limbal injury. Am J Pathol. 2000;157:1277-1281. (Pubitemid 30757950)
16. Ambati BK, Joussen AM, Kuziel WA, Adamis AP, Ambati J. Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea. 2003;22:465-467. (Pubitemid 36759041)
17. Ambati BK, Anand A, Joussen AM, Kuziel WA, Adamis AP, Ambati J. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci. 2003;44:590-593. (Pubitemid 36159703)
18. Usui T, Yamagami S, Yokoo S, Mimura T, Ono K, Amano S. Gene expression profile in corneal neovascularization identified by immunology related gene array. Mol Vis. 2004;10:832. (Pubitemid 41358210)
19. Usui T, Yamagami S, Kishimoto S, Yokoo S, Nakamura T, Amano S. Role of macrophage migration inhibitory factor in corneal neovascularization. Invest Ophthalmol Vis Sci. 2007;48:3545-3550. (Pubitemid 351261088)
20. Benson SC, Pershadsingh HA, Ho CI, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity. Hypertension. 2004;43:993-1002.
21. Schupp M, Janke J, Clausen R, Unger T, Kintscher U. Angiotensin type I receptor blockers induce peroxisome proliferators-activated receptor-gamma activity. Circulation. 2004;109:2054-2057. (Pubitemid 38620211)
22. Leung PS, Carlsson PO. Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J Mol Endocrinol. 2001;26:155-164.
23. Savaskan E, Loffler KU, Meier F, Muller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissue. Ophthalmic Res. 2004;36:312-320. (Pubitemid 40069656)
24. Mizoue S, Iwai M, Ide A, et al. Role of angiotensin II receptor subtypes in conjunctival wound healing. Curr Eye Res. 2006;31:129-136. (Pubitemid 43315881)
25. Price A, Lockhart JC, Ferrell WR, Gsell W, McLean S, Sturrock RD. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis. Arthritis Rheum. 2007;56:441-447.
26. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050. (Pubitemid 38544126)
27. Usui T, Ishida S, Yamashiro K, et al. VEGF164 (165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest Ophthalmol Vis Sci. 2004;45:368-374. (Pubitemid 38140491)
28. Otani A, Takagi H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin 2 in bovine retinal endothelial cells. Diabetes. 2001;50:867-875. (Pubitemid 32242646)
29. Sarayba MA, Li L, Tungsiripat T, et al. Inhibition of corneal neovascularization by a peroxisome proliferators-activated receptorgamma ligand. Exp Eye Res. 2005;80:435-442. (Pubitemid 40249898)
30. Yamagami S, Suzuki Y, Tsuru T. Risk factors for graft failure in penetrating keratoplasty. Acta Ophthalmol Scand. 1996;74:584-588. (Pubitemid 27042683)